5 Biotech Companies Join Forces to Develop a Thermostable SARS-CoV-2 Delta Variant VaccineBy 53Biologics|2022-05-26T16:56:59+02:00May 2nd, 2022|Read More
Biopharmaceutical companies: 4 Factors to Consider for the selection of your Biologics CDMO PartnerBy 53Biologics|2022-05-26T14:23:45+02:00April 6th, 2022|Read More
Oligofastx project, development of RNA-based therapeuticsBy 53Biologics|2022-05-26T14:02:18+02:00March 24th, 2022|Read More
Which Are Better? Biologics or Small Molecule Drugs?By 53Biologics|2022-05-26T13:56:15+02:00March 3rd, 2022|Read More
Biologics CDMO: Why You Need OneBy 53Biologics|2022-06-07T15:41:26+02:00February 23rd, 2022|Read More
Accelerating Biologics ManufacturingBy 53Biologics|2022-06-14T12:24:07+02:00February 16th, 2022|Read More
Why is Pichia Pastoris a good alternative for the production of recombinant proteins?By 53Biologics|2022-05-26T13:48:10+02:00April 15th, 2021|Read More
What is the best known living being in the scientific field?By 53Biologics|2022-05-26T13:47:18+02:00March 17th, 2021|Read More
Awarded the first place medal of the quality sealBy 53Biologics|2022-05-26T13:32:32+02:00November 18th, 2016|Read More
